Search research articles
Contact Us
Filters
Showing results (11-20 of 264) with videos related to
Page
of 27
Sort By:
Endocrinology and Metabolism Clinics of North America
|
November 14, 2021
Endocrine Disorders with Parathyroid Hormone-Independent Hypercalcemia
Jo Krogsgaard Simonsen, Lars Rejnmark
Case Reports in Endocrinology
|
March 25, 2014
Three-year successful cinacalcet treatment of secondary hyperparathyroidism in a patient with x-linked dominant hypophosphatemic rickets: a case report
Diana Grove-Laugesen, Lars Rejnmark
Calcified Tissue International
|
January 7, 2014
Clinical and radiological observations in a case series of 26 patients with fibrous dysplasia
Malissa Dawn Thomsen, Lars Rejnmark
Ugeskrift for Laeger
|
April 18, 2007
[Vitamin D and breast cancer]
Lars Rejnmark Nielsen, Leif Mosekilde
The Journal of Clinical Endocrinology and Metabolism
|
May 17, 2024
Is it Time for a Genuine Placebo-controlled Trial on Effects of Vitamin D?
Lise Sofie Bislev, Lars Rejnmark
Current Osteoporosis Reports
|
March 31, 2020
Effects of PTH and PTH Hypersecretion on Bone: a Clinical Perspective
Lars Rejnmark, Henriette Ejlsmark-Svensson
Clinical Endocrinology
|
August 22, 2019
Expanding the spectrum of genetic variants in the calcium-sensing receptor (CASR) gene in hypercalcemic individuals
Peter H Nissen, Lars Rejnmark
Ugeskrift for Laeger
|
April 10, 2008
[Osteoporosis--new therapeutic possibilities. The Danish Bone Society]
Bente L Langdahl, Lars Rejnmark,
Complementary Therapies in Medicine
|
January 22, 2024
Effects of melatonin on blood pressure, arterial stiffness and quality of life in postmenopausal women: A randomized controlled trial
Anne Kristine Amstrup, Lars Rejnmark
Scandinavian Journal of Public Health
|
July 25, 2006
Socioeconomic aspects of fractures within universal public healthcare: a nationwide case-control study from Denmark
Peter Vestergaard, Lars Rejnmark, Leif Mosekilde
Page
of 27
Search research articles
Search
Showing results (11-20 of 264) with videos related to
Sort By:
Page
of 27
Endocrinology and Metabolism Clinics of North America
|
November 14, 2021
Endocrine Disorders with Parathyroid Hormone-Independent Hypercalcemia
Jo Krogsgaard Simonsen, Lars Rejnmark
Case Reports in Endocrinology
|
March 25, 2014
Three-year successful cinacalcet treatment of secondary hyperparathyroidism in a patient with x-linked dominant hypophosphatemic rickets: a case report
Diana Grove-Laugesen, Lars Rejnmark
Calcified Tissue International
|
January 7, 2014
Clinical and radiological observations in a case series of 26 patients with fibrous dysplasia
Malissa Dawn Thomsen, Lars Rejnmark
Ugeskrift for Laeger
|
April 18, 2007
[Vitamin D and breast cancer]
Lars Rejnmark Nielsen, Leif Mosekilde
The Journal of Clinical Endocrinology and Metabolism
|
May 17, 2024
Is it Time for a Genuine Placebo-controlled Trial on Effects of Vitamin D?
Lise Sofie Bislev, Lars Rejnmark
Current Osteoporosis Reports
|
March 31, 2020
Effects of PTH and PTH Hypersecretion on Bone: a Clinical Perspective
Lars Rejnmark, Henriette Ejlsmark-Svensson
Clinical Endocrinology
|
August 22, 2019
Expanding the spectrum of genetic variants in the calcium-sensing receptor (CASR) gene in hypercalcemic individuals
Peter H Nissen, Lars Rejnmark
Ugeskrift for Laeger
|
April 10, 2008
[Osteoporosis--new therapeutic possibilities. The Danish Bone Society]
Bente L Langdahl, Lars Rejnmark,
Complementary Therapies in Medicine
|
January 22, 2024
Effects of melatonin on blood pressure, arterial stiffness and quality of life in postmenopausal women: A randomized controlled trial
Anne Kristine Amstrup, Lars Rejnmark
Scandinavian Journal of Public Health
|
July 25, 2006
Socioeconomic aspects of fractures within universal public healthcare: a nationwide case-control study from Denmark
Peter Vestergaard, Lars Rejnmark, Leif Mosekilde
Page
of 27